Concepedia

Alain Luxembourg

AL

Statistics

Publications

61

Citations

4.8K

H-Index

34

Active since

1987

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Moffitt Cancer Center

Medical University of Vienna

Danish Cancer Society

University of Copenhagen

Alain Luxembourg is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in vaccinology, vaccination, and immunization.

Publications per year

1987–2024

61

Publications

61

A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women

Elmar A. Joura, Anna R. Giuliano, Ole‐Erik Iversen et al. · New England Journal of Medicine · 2015 · 1.4K citations · Full text

, , +16

Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16–26 years: a randomised, double-blind trial

Warner K. Huh, Elmar A. Joura, Anna R. Giuliano et al. · The Lancet · 2017 · 459 citations · Full text

, , +16

Immunogenicity of the 9-Valent HPV Vaccine Using 2-Dose Regimens in Girls and Boys vs a 3-Dose Regimen in Women

Ole‐Erik Iversen, María J. Miranda, Àngels Ulied et al. · JAMA · 2016 · 209 citations

, , +16

Final analysis of a 14-year long-term follow-up study of the effectiveness and immunogenicity of the quadrivalent human papillomavirus vaccine in women from four nordic countries

Susanne K. Kjær, Mari Nygård, Karin Sundström et al. · EClinicalMedicine · 2020 · 195 citations · Full text

, , +17

Attribution of 12 High-Risk Human Papillomavirus Genotypes to Infection and Cervical Disease

Elmar A. Joura, Kevin A. Ault, F. Xavier Bosch et al. · Cancer Epidemiology Biomarkers & Prevention · 2014 · 180 citations · Full text

, , +17

1–5 of 61